A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia. (Record no. 26351254)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02386 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517112515.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201802s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1557-3265 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1158/1078-0432.CCR-16-1274 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Pratz, Keith W |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180213 |
| 245 00 - TITLE STATEMENT | |
| Title | A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Date of publication, distribution, etc. | Feb 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 899-907 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzimidazoles |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carboplatin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug-Related Side Effects and Adverse Reactions |
| General subdivision | pathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fanconi Anemia Complementation Group D2 Protein |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Biphenotypic, Acute |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Myelomonocytic, Chronic |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Myeloproliferative Disorders |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Poly (ADP-Ribose) Polymerase-1 |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Topotecan |
| General subdivision | administration & dosage |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rudek, Michelle A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gojo, Ivana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Litzow, Mark R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McDevitt, Michael A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ji, Jiuping |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Karnitz, Larry M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Herman, James G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kinders, Robert J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Smith, B Douglas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gore, Steven D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Carraway, Hetty E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Showel, Margaret M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gladstone, Douglas E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Levis, Mark J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tsai, Hua-Ling |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rosner, Gary |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chen, Alice |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kaufmann, Scott H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Karp, Judith E |
| 773 0# - HOST ITEM ENTRY | |
| Title | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Related parts | vol. 23 |
| -- | no. 4 |
| -- | p. 899-907 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1158/1078-0432.CCR-16-1274">https://doi.org/10.1158/1078-0432.CCR-16-1274</a> |
| Public note | Available from publisher's website |
No items available.